Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease After Haploidentical/matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Transfusion-dependent Thalassemia
Clinical trial NCT06657391 · RECRUITING
Trial details
- NCT number
- NCT06657391
- Sponsor
- Rongrong Liu
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2027-09-30
- Enrollment
- 396
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.